skip to Main Content

MRIGLOBAL PROVIDES BROAD RANGE OF SUPPORT TO THE U.S. DEPARTMENT OF DEFENSE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL AND BIOLOGICAL DEFENSE (JPEO-CBD)

A key task under the Homeland Defense Technical Area Tasks contract awarded to MRIGlobal will provide innovative work in chemical and biological defense.

Kansas City, Mo. – MRIGlobal was awarded the Research, Development, Test and Evaluation, and Strategic Initiatives task under the Homeland Defense Technical Area Tasks (HD TAT) contract with DTIC on 10 February 2017.

MRIGlobal will provide a broad range of technical services to the defense community to study, analyze, advise, research, and develop deliverables to advance Homeland Defense (HD) related scientific and technical information (STI).

The contract is intended to provide defense researchers and acquisitions teams with access to leading capabilities and experts in Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) defense areas.

“The projects we’ll conduct on this task build upon our more than 70 years of expertise supporting our Nation’s vital functions protecting us from the continuing CBRNE threat” said Thomas M. Sack, Ph.D., President and Chief Executive Officer, MRIGlobal. “We are excited to begin this new chapter in our work to serve our defense community.”

“We have some of the best staff and facilities in the world” said Robert Conklin, Vice-President for Technical Operations, MRIGlobal. “This contract allows us to continue to provide these services to the entire Defense Enterprise.”